Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading ENZO BIOCHEM INC chart...

About the Company

We do not have any company description for ENZO BIOCHEM INC at the moment.

Exchange

NYSE

$12M

Total Revenue

85

Employees

$54M

Market Capitalization

-4.68

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ENZ News

Here's Why Laughing Water Capital Sold Enzo Biochem Inc (ENZ)

2mon ago, source: Hosted on MSN

Laughing Water Capital featured stocks such as Enzo Biochem, Inc. (NYSE:ENZ) in the fourth quarter 2023 investor letter. Headquartered in Farmingdale, New York, Enzo Biochem, Inc. (NYSE ...

Enzo Biochem gets grant for method for detecting enzymes adding functional groups to compounds

2d ago, source: Pharmaceutical Technology

Detect and quantify modified compounds with Enzo Biochem Inc's patented method. Learn how to isolate compounds, add functional groups, and detect enzymes in samples efficiently.

Enzo Biochem (NYSE: ENZ)

6d ago, source: The Motley Fool

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable ...

Enzo Biochem Inc ENZ

11d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update

1mon ago, source: Yahoo Finance

FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024.

Enzo Biochem: Fiscal Q2 Earnings Snapshot

1mon ago, source: SFGate

FARMINGDALE, N.Y. (AP) — FARMINGDALE, N.Y. (AP) — Enzo Biochem Inc. (ENZ) on Wednesday reported a loss of $3.1 million in its fiscal second quarter. The Farmingdale, New York-based company ...

Enzo Biochem Reports 2008 Fiscal First Quarter Results

21d ago, source: ADVFN

Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications ...

Enzo Biochem Inc ENZ

22d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...